Peer review reports
From: Imatinib treatment of poor prognosis mesenchymal-type primary colon cancer: a proof-of-concept study in the preoperative window period (ImPACCT)
Original Submission |
29 Nov 2016 |
Submitted |
Original manuscript
|
13 Feb 2017 |
Author responded |
Author comments - Inge Ubink
|
Resubmission - Version 2 |
13 Feb 2017 |
Submitted |
Manuscript version 2
|
Publishing |
5 Apr 2017 |
Editorially accepted |
|
19 Apr 2017 |
Article published |
10.1186/s12885-017-3264-y
|
Learn about peer review